ArticleJournal of the American Society of Cytopathology

PD-L1 testing using the clone 22C3 pharmDx kit for selection of patients with non-small cell lung cancer to receive immune checkpoint inhibitor therapy: are cytology cell blocks a viable option?

Vanda F Torous et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.